Allison Stover Fiscalini

University of California, San Francisco — United States

Medicine · Health Sciences

12h-index973citations58works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Global Cancer Incidence and Screening(24), BRCA gene mutations in cancer(16), Nutrition, Genetics, and Disease(11), Economic and Financial Impacts of Cancer(6), Cancer survivorship and care(5)

Publications57 total

WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design
2025Open Access
Germline Pathogenic Variants Among Women Without a History of Breast Cancer
JAMA Internal Medicine·2025Open Access
Risk-Based vs Annual Breast Cancer Screening
JAMA·2025· 4 citedOpen Access
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design
2025· 1 citedOpen Access
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial
Genome Medicine·2025· 5 citedOpen Access
Relationship Between Perceived COVID-19 Risk and Change in Perceived Breast Cancer Risk: Prospective Observational Study
JMIR Cancer·2024Open Access
Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study
npj Breast Cancer·2024· 3 citedOpen Access
Accuracy of patient-reported gynecologic cancer diagnoses and procedures at a large academic medical center
Gynecologic Oncology·2024
Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study
Public Health Genomics·2024· 2 citedOpen Access
Relationship between Perceived Risk and Preventive Health Behaviors during the COVID-19 Pandemic -- The WISDOM Study
2024Open Access
Abstract B084: Association between race and ethnicity, area deprivation, and exposure to environmental toxins in the WISDOM clinical trial population
Cancer Research·2024
Abstract A032: Low non-immune stromal cell levels and high hypoxic tumor microenvironments are associated with pathologic complete response in the neoadjuvant I-SPY2 TRIAL
Cancer Research·2024
Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study
JCO Clinical Cancer Informatics·2023· 1 citedOpen Access
Cost of breast cancer screening in the USA: Comparison of current practice, advocated guidelines, and a personalized risk-based approach.
Journal of Clinical Oncology·2023· 4 cited
Relationship between Perceived Risk and Preventive Health Behaviors during the COVID-19 Pandemic -- The WISDOM Study
2023
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study
2023Open Access
Relationship Between Perceived COVID-19 Risk and Change in Perceived Breast Cancer Risk: Prospective Observational Study (Preprint)
2023
Abstract P3-03-24: The WISDOM Study: Early Ascertainment of Breast Cancer Diagnoses by Utilizing Self-Reported Questionnaires and Data Warehouse Electronic Health Records
Cancer Research·2023
Abstract PD14-07: PD14-07 Associations of Breast Cancer Risk Level and Prediction of Tumor Aggressiveness in the Athena Breast Health Network
Cancer Research·2023· 1 cited
Distribution of breast cancer molecular subtypes within receptor classifications: Lessons from the I-SPY2 Trial and FLEX Registry.
Journal of Clinical Oncology·2022· 1 cited
page 1 of 3Next →

Frequent Co-authors

Laura J. Esserman(40), Arash Naeim(22), Yiwey Shieh(21), Lisa Madlensky(19), Martin Eklund(18), Elad Ziv(18), Laura van ‘t Veer(17), Hoda Anton‐Culver(16), Alexander D. Borowsky(16), Andrea Z. LaCroix(16), Jeffrey A. Tice(16), Leah Sabacan(16), Diane Heditsian(14), Barbara A. Parker(14), Neil S. Wenger(14), Celia P. Kaplan(13), Deborah Goodman(13), Susie Brain(12), Robert A. Hiatt(10), Andrea Kaster(10)